Maple Securities USA’s Zimmer Biomet ZBH Stock Holding History

Maple Securities USA’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2,774	Closed	-$316K	–	324
2015 Q1	$316K	Buy	+2,774	New	+$317K	0.03%	168
2014 Q4	–	Sell	-7,274	Closed	-$710K	–	273
2014 Q3	$710K	Buy	+7,274	New	+$715K	0.08%	97
2013 Q3	–	Sell	-14,624	Closed	-$1.06M	–	528
2013 Q2	$1.06M	Buy	+14,624	New	+$1.09M	0.1%	173

Other funds holding ZBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Maple Securities USA's ZBH Position: Q2 2015 in Review

Maple Securities USA sold out of Zimmer Biomet (ZBH) in Q2 2015, closing a stake of 2,774 shares — an estimated $316K sold.

Maple Securities USA first reported a position in ZBH in Q2 2013 and held it in 3 quarters. The position peaked at $1.06M in Q2 2013. 749 funds tracked by Wall St. Rank hold ZBH as of Q2 2015.

Maple Securities USA reported no remaining Zimmer Biomet position as of Q2 2015 after selling out during the quarter.
Maple Securities USA sold 2,774 Zimmer Biomet shares in Q2 2015, an estimated $316K.
Maple Securities USA first reported a position in Zimmer Biomet in Q2 2013 and held it in 3 quarters.
Maple Securities USA's Zimmer Biomet position peaked at $1.06M in Q2 2013.
749 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2015.

Based on Maple Securities USA's 13F filing for Q2 2015, filed 24 Jul 2015.